This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,359.88, is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine, to support military healthcare programs.
AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to the military globally. This specific award is likely a delivery order against that larger IDC contract. The contract has no set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and the contract will be performed in Conshohocken, Pennsylvania.
Generated 3/9/25, 12:46 AM